SEQIRUS

Manufacturing Influenza vaccines

Filings
45
Clients
1
Total Income
Years Active
2016–2026

Filings

Year Client Period Income Expenses Doc
2021 SEQIRUS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$140,000
2021 SEQIRUS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$100,000
2021 SEQIRUS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$100,000
2020 SEQIRUS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$100,000
2020 SEQIRUS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$130,000
2020 SEQIRUS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$160,000
2020 SEQIRUS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$120,000
2019 SEQIRUS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$110,000
2019 SEQIRUS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$120,000
2019 SEQIRUS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$110,000
Prev Page 3 of 5  ·  45 filings Next

Clients Represented

ClientFilingsTotal Income
SEQIRUS 45

Lobbyists

NameDisclosed Prior Position
CHRISTINE FARQUHARSON OMB, Health Division, Program Examiner (2010-2021)
PHYLLIS FROSST